Bacil Pharma Ltd vs Biofil Chemicals Pharmaceuticals Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 04, 2026

Key Highlights

The Latest Trading Price of Bacil Pharma Ltd is ₹ 56.95 as of 30 Apr 15:30 . The P/E Ratio of Bacil Pharma Ltd changed from 146.5 on March 2025 to 146.5 on March 2025 . This represents a CAGR of 0.00% over 1 yearsThe P/E Ratio of Biofil Chemicals & Pharmaceuticals Ltd changed from 86.4 on March 2021 to 121 on March 2025 . This represents a CAGR of 6.97% over 5 years The Market Cap of Bacil Pharma Ltd changed from ₹ 1.84 crore on March 2021 to ₹ 60.99 crore on March 2025 . This represents a CAGR of 101.41% over 5 yearsThe Market Cap of Biofil Chemicals & Pharmaceuticals Ltd changed from ₹ 106.81 crore on March 2021 to ₹ 66.92 crore on March 2025 . This represents a CAGR of -8.93% over 5 years The revenue of Bacil Pharma Ltd for the Dec '25 is ₹ 0.06 crore as compare to the Sep '25 revenue of ₹ 0.05 crore. This represent the growth of 20% The revenue of Biofil Chemicals & Pharmaceuticals Ltd for the Dec '25 is ₹ 0.93 crore as compare to the Sep '25 revenue of ₹ 13.6 crore. This represent the decline of -93.16% The ebitda of Bacil Pharma Ltd for the Dec '25 is ₹ 0.04 crore as compare to the Sep '25 ebitda of ₹ 0.02 crore. This represent the growth of 100% The ebitda of Biofil Chemicals & Pharmaceuticals Ltd for the Dec '25 is ₹ 0.17 crore as compare to the Sep '25 ebitda of ₹ 0.18 crore. This represent the decline of -5.56% The net profit of Bacil Pharma Ltd changed from ₹ -0.03 crore to ₹ 0.04 crore over 7 quarters. This represents a CAGR of NaN% The net profit of Biofil Chemicals & Pharmaceuticals Ltd changed from ₹ 0.17 crore to ₹ 0.08 crore over 7 quarters. This represents a CAGR of -35.00% The Dividend Payout of Bacil Pharma Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Biofil Chemicals & Pharmaceuticals Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 years .

About Bacil Pharma Ltd

Incorporated as a private limited company in Maharashtra in May '87, Bacil Pharma (BPL) was converted into a public limited company in Oct.'90.
The main business activity of the Company is Pharmaceutical. Bal Pharma is a fully integrated and leading Indian pharmaceutical company specialized in Prescription drugs, Branded Formulations, APIs, Generic & OTC products, Intravenous Infusions and Bulk Drugs.
Domestic operations are spread across pan India.
The company has strong field force of 500 plus, spread over various States and Districts.
It has a strong distribution set up, with Super Stockist in all the States and stockists for retail coverage.

About Biofil Chemicals & Pharmaceuticals Ltd

Biofil Chemicals & Pharmaceuticals Limited (BCPL) was incorporated as a Private Limited Company on 4 Jan.'85 for manufacturing and trading of Pharmaceuticals products.
Later on, the Company was converted into a Public Limited Company on 7 May '92.
The Company deals in providing job work facility in respect of manufacturing of pharmaceuticals drug.
It runs the business via two unit viz Pharmaceutical Division & Chemicals Division. In Feb.'96, the company had come out with a rights-cum-public issue at a premium of Rs 7.50 and at a premium of Rs 12.50 respectively, both aggregating Rs 23.21 cr, to part-finance its expansion and diversification into bulk drugs and pharmaceutical formulations.
The company currently manufactures pharmaceutical formulations like injections, capsules, eye-drops and dry syrups at its plant located in Indore.

FAQs for the comparison of Bacil Pharma Ltd and Biofil Chemicals & Pharmaceuticals Ltd

Which company has a larger market capitalization, Bacil Pharma Ltd or Biofil Chemicals & Pharmaceuticals Ltd?

Market cap of Bacil Pharma Ltd is 81 Cr while Market cap of Biofil Chemicals & Pharmaceuticals Ltd is 54 Cr

What are the key factors driving the stock performance of Bacil Pharma Ltd and Biofil Chemicals & Pharmaceuticals Ltd?

The stock performance of Bacil Pharma Ltd and Biofil Chemicals & Pharmaceuticals Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Bacil Pharma Ltd and Biofil Chemicals & Pharmaceuticals Ltd?

As of May 4, 2026, the Bacil Pharma Ltd stock price is INR ₹56.95. On the other hand, Biofil Chemicals & Pharmaceuticals Ltd stock price is INR ₹33.73.

How do dividend payouts of Bacil Pharma Ltd and Biofil Chemicals & Pharmaceuticals Ltd compare?

To compare the dividend payouts of Bacil Pharma Ltd and Biofil Chemicals & Pharmaceuticals Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.